Fri, Dec 26, 2014, 5:27 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Exact Sciences Corporation Message Board

  • techtrader79 techtrader79 Oct 16, 2012 8:18 AM Flag

    EXAS Trial failure coming?

    Something isn't right, is setback announcement imminent? Anyone?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • October 16, 2012

      "Item 7.01. Regulation FD Disclosure

      On October 16, 2012, Exact Sciences Corporation (the "Company") released new study data for its colorectal cancer screening test at the International Conference on Frontiers in Cancer Prevention Research, a meeting of the American Association for Cancer Research. The primary purpose of the study was to establish the analytical performance of the test methodology in advance of completion of the Company's pivotal clinical trial for the test (known as the DeeP-C trial). The study demonstrated 98% sensitivity for cancer. It also demonstrated promising results for detecting the pre-cancers most likely to develop into colon cancer, with 83% sensitivity for high grade dysplasia and 57% for pre-cancer = 1 cm. All sensitivities were reported at a specificity of 90%.
      The study specimens were collected at 36 study centers either before colonoscopy bowel preparation in screening and surveillance subjects, or at least seven days post-colonoscopy from subjects recruited with colorectal cancer or pre-cancers. A total of 1003 patient samples were analyzed in the study."

      Sentiment: Strong Buy

    • Hey Dip, it was profit taking after the Barrons article and now some weak hands thinking the trial is over in a month. Tell me why the expansion if news is going to be bad?

 
EXAS
28.52+0.9200(+3.33%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.